FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, and concerns applications of amphiphilic block copolymers for treating and preventing cancer, particularly by reduced cancer cell growth and proliferation rate. Besides, the amphiphilic block copolymers can be used for blocking of platelet and fibroblast growth factor linking with related receptors on a membrane. Preferential block copolymers contain a basic hydrophobic chain, preferentially a polypropylene oxide chain whereto there are attached at least two hydrophilic side chains, preferentially a polyethylene oxide chain with mean ethylene oxide making less than 80 % of said amphiphilic block copolymer and molecular weight of the basic hydrophobic polymeric chain making at least 2000 g/mol.
EFFECT: invention provides new chemotherapeutic polymer drug for various types of cancer, having an effect of reduced cancer cell proliferation rate.
18 cl, 13 dwg, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND COMPOSITION FOR TREATING CANCER | 2011 |
|
RU2541100C2 |
| SUPERCRITICAL LIQUID EXTRACT CONTAINING CARDIAC GLYCOSIDE | 2006 |
|
RU2398591C2 |
| APILIMOD FOR USE IN TREATING RENAL CANCER | 2015 |
|
RU2727802C2 |
| PHARMACEUTICAL COMPOSITIONS FOR PERORAL DELIVERY OF DIINDOLYLMETHANE (DIM) AND METHODS FOR APPLICATION OF THESE COMPOSITIONS | 2009 |
|
RU2409363C9 |
| COMPOSITIONS AND METHODS FOR THERAPEUTIC MEANS DELIVERY | 2011 |
|
RU2632445C2 |
| POLYMER SYSTEMS OF DELIVERING ACTIVE SUBSTANCES | 2009 |
|
RU2523714C2 |
| PARTICLE AND PHARMACEUTICAL COMPOSITION CONTAINING INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORE-SHELL STRUCTURE AND METHOD OF MANUFACTURE THEREOF | 2018 |
|
RU2745070C1 |
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT | 2019 |
|
RU2794261C2 |
| COMPOSITIONS CONTAINING BIOLOGICAL AGENT | 1996 |
|
RU2166934C2 |
| METHODS OF TREATING CANCER USING APILIMOD | 2016 |
|
RU2738934C2 |
